AI Drug Developer Basecamp Hits $800 Million Valuation
AI-based drug developer Basecamp raised $140 million and is now valued at $800 million, The Economic Times reports, placing the firm near unicorn territory.
Topic
Basecamp
Topic
Topic
Topic
AI-based drug developer Basecamp raised $140 million and is now valued at $800 million, The Economic Times reports, placing the firm near unicorn territory.